Cytokinetics Inc (CYTK)
- Exchange
- NASDAQ
- Symbol
- CYTK
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
- Country
- USA
Stock price
At close: October 28, 2025
-
Open59.88
-
High62.15
-
Low59.52
-
Close61.97
-
Volume1,939,490
Financial ratios
Dec 31, 2024